165
Followers
1
Posts
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
70.750 -
-1.900
(-2.62%)
Range
70.100 - 75.000
(6.99%)
Open
72.650
Previous Close
72.650
Bid Price
70.600
Bid Volume
('000)
2
Ask Price
70.750
Ask Volume
('000)
1.5
Volume
('000)
857.1
Value
61,050,043
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
165
Loading Chart...
Please login to view stock data and analysis
